Exact Mass: 580.1581

Exact Mass Matches: 580.1581

Found 81 metabolites which its exact mass value is equals to given mass value 580.1581, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Gambiriin A1

2-(3,4-dihydroxyphenyl)-8-[1-(3,4-dihydroxyphenyl)-2-hydroxy-3-(2,4,6-trihydroxyphenyl)propyl]-3,4-dihydro-2H-1-benzopyran-3,5,7-triol

C30H28O12 (580.1581)

Gambiriin A1 is found in herbs and spices. Gambiriin A1 is isolated from Sanguisorba officinalis (burnet bloodwort). Isolated from Sanguisorba officinalis (burnet bloodwort). Gambiriin A1 is found in tea and herbs and spices.

Gambriin A3

Gambiriin A3

C30H28O12 (580.1581)

Gambiriin A2

C30H28O12 (580.1581)

6'-p-Coumaroylprunin

(3,4,5-Trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl]oxy}oxan-2-yl)methyl (2E)-3-(4-hydroxyphenyl)prop-2-enoic acid

C30H28O12 (580.1581)

6-p-Coumaroylprunin is found in cashew nut. 6-p-Coumaroylprunin is isolated from Anacardium occidentale (cashew). Isolated from Anacardium occidentale (cashew). Prunin 6-p-coumarate is found in cashew nut and nuts.

Fostamatinib

{[6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}imino)-2,2-dimethyl-3-oxo-2H,3H,4H,5H,6H-pyrido[3,2-b][1,4]oxazin-4-yl]methoxy}phosphonic acid

C23H26FN6O9P (580.1483)

B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Nutlin-3

4-[4,5-bis(4-chlorophenyl)-2-[4-methoxy-2-(propan-2-yloxy)phenyl]-4,5-dihydro-1H-imidazole-1-carbonyl]piperazin-2-one

C30H30Cl2N4O4 (580.1644)

Nutlin-3 is a commercial available p53-MDM2 inhibitor, with Ki of 90 nM.

4,2,3,4-Tetrahydroxychalcone 4-O-(6-O-p-coumaroyl)glucoside

C30H28O12 (580.1581)

4,2,3,4-Tetrahydroxychalcone 4-O-(2-O-p-coumaroyl)glucoside

4,2,3,4-Tetrahydroxychalcone 4-O- (2"-O-p-coumaroyl) glucoside

C30H28O12 (580.1581)

Taxifolin 3-(3-cinnamoylrhamnoside)

3,5,7,3,4-Pentahydroxyflavanone 3- (3-cinnamoylrhamnoside)

C30H28O12 (580.1581)

Prunin 3-p-coumarate

C30H28O12 (580.1581)

Chalconaringenin 2-(6-p-coumarylglucoside)

C30H28O12 (580.1581)

Naringenin 7-(2-p-Coumaroylglucoside)

5,7,4-Trihydroxyflavanone 7-(2-p-Coumaroylglucoside)

C30H28O12 (580.1581)

6-[1-(3,4-Dihydroxyphenyl)-2-hydroxy-3-(3,4,5-trihydroxyphenyl)propyl]-7,8,3,4-tetrahydroxyflavan

C30H28O12 (580.1581)

Prunin 6'-p-coumarate

5,7,4-Trihydroxyflavanone 7-O-glucoside-6"-p-coumarate

C30H28O12 (580.1581)

leufolin A|{6-[4-(5,7-dihydroxy-4-oxo-3,4-dihydro-2H-chromen-2-yl)phenoxy]-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl}methyl (E)-3-(4-hydroxyphenyl)-2-propenoate

C30H28O12 (580.1581)

6-[1-(3,4-Dihydroxyphenyl)-2-hydroxy-3-(3,4,5-trihydroxyphenyl)propyl]-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,7,8-triol

C30H28O12 (580.1581)

(2S)-eriodictyol 7-O-(2-O-trans-cinnamoyl)-beta-D-glucopyranoside|visartiside A

C30H28O12 (580.1581)

uroleuconaphin B1

C30H28O12 (580.1581)

MCULE-8476805700

C30H28O12 (580.1581)

4alpha-Hydroxy-Rhododactynaphin

C30H28O12 (580.1581)

(2S)-eriodictyol 7-O-(6-O-trans-cinnamoyl)-beta-D-glucopyranoside|visartiside B

C30H28O12 (580.1581)

Nutlin-3

Nutlin (3)

C30H30Cl2N4O4 (580.1644)

Nutlin-3 is a commercial available p53-MDM2 inhibitor, with Ki of 90 nM.

[(2S,3R,4S,5R,6R)-3,5-dihydroxy-2-[[5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydrochromen-7-yl]oxy]-6-(hydroxymethyl)oxan-4-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate

NCGC00385356-01![(2S,3R,4S,5R,6R)-3,5-dihydroxy-2-[[5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydrochromen-7-yl]oxy]-6-(hydroxymethyl)oxan-4-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate

C30H28O12 (580.1581)

[(2R,3S,4S,5R,6S)-6-[2,3-dihydroxy-4-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]phenoxy]-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate

C30H28O12 (580.1581)

(+)-Nutlin-3

4-(4,5-bis(4-chlorophenyl)-2-(2-isopropoxy-4-methoxyphenyl)-4,5-dihydro-1H-imidazole-1-carbonyl)piperazin-2-one

C30H30Cl2N4O4 (580.1644)

(-)-Nutlin-3

4-(4,5-bis(4-chlorophenyl)-2-(2-isopropoxy-4-methoxyphenyl)-4,5-dihydro-1H-imidazole-1-carbonyl)piperazin-2-one

C30H30Cl2N4O4 (580.1644)

Prunin 6-p-coumarate

C30H28O12 (580.1581)

Nutlin (3)

()-4-[4,5-bis-(4-chlorophenyl)-2-(2-isopropoxy-4-methoxy-phenyl)-4,5-dihydro-imidazole-1-carbonyl]-piperazin-2-one

C30H30Cl2N4O4 (580.1644)

Nutlin-3 is a commercial available p53-MDM2 inhibitor, with Ki of 90 nM.

6''-p-Coumaroylprunin

(3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl]oxy}oxan-2-yl)methyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate

C30H28O12 (580.1581)

N-(5-chloro-2-methoxyphenyl)-3-hydroxy-4-[[2-methoxy-5-[(phenylamino)carbonyl]phenyl]azo]naphthalene-2-carboxamide

C32H25ClN4O5 (580.1513)

Nutlin-3b

C30H30Cl2N4O4 (580.1644)

Nutlin-3b is a p53/MDM2 inhibitor with an IC50 of 13.6 μM. Nutlin-3b is 150 times less potent in binding to MDM2 than Nutlin-3a[1].

Nutlin-3a

C30H30Cl2N4O4 (580.1644)

C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent > C162996 - MDM2 Inhibitor Nutlin-3a (Rebemadlin), an active enantiomer of Nutlin-3, is a potent murine double minute (MDM2) inhibitor (IC50=90 nM). Nutlin-3a inhibits MDM2-p53?interactions and stabilizes the p53 protein, and induces cell autophagy and apoptosis. Nutlin-3a has the potential for the study of TP53?wild-type ovarian carcinomas[1][2].

Acelarin

C25H27F2N4O8P (580.1534)

Pigment Red 184

C32H25ClN4O5 (580.1513)

7-[3-O-(4-Hydroxycinnamoyl)-beta-D-glucopyranosyloxy]-4,5-dihydroxyflavanone

C30H28O12 (580.1581)

Fostamatinib

Fostamatinib (R788)

C23H26FN6O9P (580.1483)

4-[6-O-(4-Hydroxycinnamoyl)beta-D-glucopyranosyloxy]-2,3,4-trihydroxychalcone

C30H28O12 (580.1581)

leufolin B

C30H28O12 (580.1581)

A flavanone glycoside that is 6,8,4-trihydroxyflavanone attached to a 6-O-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-beta-D-glucopyranosyl moiety at position 4 via a glycosidic linkage. Isolated from Leucas urticifolia, it acts as a cholinesterase inhibitor.

leufolin A

C30H28O12 (580.1581)

A flavanone glycoside that is (S)-naringenin attached to a 6-O-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-beta-D-glucopyranosyl moiety at position 4 via a glycosidic linkage. Isolated from Leucas urticifolia, it acts as a cholinesterase inhibitor.

(2S,3S,4R,5R)-6-[4-[2-(benzenesulfinyl)ethyl]-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid

C29H28N2O9S (580.1515)

Gambiriin A1

C30H28O12 (580.1581)

Gambiriin A3

C30H28O12 (580.1581)

6-p-Coumaroylprunin

C30H28O12 (580.1581)

2-(3,4-dihydroxyphenyl)-8-[1-(3,4-dihydroxyphenyl)-2-hydroxy-3-(2,4,6-trihydroxyphenyl)propyl]-3,4-dihydro-2H-1-benzopyran-3,5,7-triol

C30H28O12 (580.1581)

(6-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3-phenylprop-2-enoate

C30H28O12 (580.1581)

4,5-dihydroxy-2-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-6-(hydroxymethyl)oxan-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

C30H28O12 (580.1581)

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}oxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C30H28O12 (580.1581)

(1r,3s,4r,5r,7r,8s,16s,24r,26r,27s)-11,13,16,18,20,27-hexahydroxy-5,7,24,26-tetramethyl-2,6,25,30-tetraoxaoctacyclo[15.11.1.1¹,⁴.0³,⁸.0³,¹⁶.0¹⁰,¹⁵.0²¹,²⁹.0²³,²⁸]triaconta-10,12,14,17(29),18,20,23(28)-heptaene-9,22-dione

(1r,3s,4r,5r,7r,8s,16s,24r,26r,27s)-11,13,16,18,20,27-hexahydroxy-5,7,24,26-tetramethyl-2,6,25,30-tetraoxaoctacyclo[15.11.1.1¹,⁴.0³,⁸.0³,¹⁶.0¹⁰,¹⁵.0²¹,²⁹.0²³,²⁸]triaconta-10,12,14,17(29),18,20,23(28)-heptaene-9,22-dione

C30H28O12 (580.1581)

(2s,3s,4r,5s,6s)-2-{[(2r,3s)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-2,3-dihydro-1-benzopyran-3-yl]oxy}-3,5-dihydroxy-6-methyloxan-4-yl (2e)-3-phenylprop-2-enoate

C30H28O12 (580.1581)

(2s,3s,4r,5r,6s)-2-{[(2r,3r)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-2,3-dihydro-1-benzopyran-3-yl]oxy}-3,5-dihydroxy-6-methyloxan-4-yl (2e)-3-phenylprop-2-enoate

C30H28O12 (580.1581)

3'-o-trans-cinnamoyl-astilbin

C30H28O12 (580.1581)

{"Ingredient_id": "HBIN009384","Ingredient_name": "3'-o-trans-cinnamoyl-astilbin","Alias": "NA","Ingredient_formula": "C30H28O12","Ingredient_Smile": "CC1C(C(C(C(O1)OC2C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)OC(=O)C=CC5=CC=CC=C5)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3700","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(2s,3r,4s,5s,6r)-4,5-dihydroxy-2-{[(2r)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-6-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C30H28O12 (580.1581)

(6-{2,3-dihydroxy-4-[3-(4-hydroxyphenyl)prop-2-enoyl]phenoxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3-(4-hydroxyphenyl)prop-2-enoate

C30H28O12 (580.1581)

(3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}oxan-2-yl)methyl 3-(4-hydroxyphenyl)prop-2-enoate

C30H28O12 (580.1581)

(2s,3r,4s,5s,6r)-4,5-dihydroxy-2-{[(2s)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-6-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C30H28O12 (580.1581)

visartiside a

C30H28O12 (580.1581)

3,5-dihydroxy-2-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-6-(hydroxymethyl)oxan-4-yl 3-(4-hydroxyphenyl)prop-2-enoate

C30H28O12 (580.1581)

(1s,9r,11r,12s,17s,25s,26r,28r,29r)-5,12,17,20,22,29-hexahydroxy-9,11,26,28-tetramethyl-2,10,27-trioxaheptacyclo[15.12.0.0¹,²⁵.0³,¹⁶.0⁶,¹⁵.0⁸,¹³.0¹⁸,²³]nonacosa-3,5,8(13),15,18,20,22-heptaene-7,14,24-trione

(1s,9r,11r,12s,17s,25s,26r,28r,29r)-5,12,17,20,22,29-hexahydroxy-9,11,26,28-tetramethyl-2,10,27-trioxaheptacyclo[15.12.0.0¹,²⁵.0³,¹⁶.0⁶,¹⁵.0⁸,¹³.0¹⁸,²³]nonacosa-3,5,8(13),15,18,20,22-heptaene-7,14,24-trione

C30H28O12 (580.1581)

ethyl 2-(3,4-dihydroxyphenyl)-4-(3-{[3-(3,4-dihydroxyphenyl)-1-methoxy-1-oxopropan-2-yl]oxy}-3-oxoprop-1-en-1-yl)-7-hydroxy-2,3-dihydro-1-benzofuran-3-carboxylate

C30H28O12 (580.1581)

5,12,17,20,22,29-hexahydroxy-9,11,26,28-tetramethyl-2,10,27-trioxaheptacyclo[15.12.0.0¹,²⁵.0³,¹⁶.0⁶,¹⁵.0⁸,¹³.0¹⁸,²³]nonacosa-3,5,8(13),15,18,20,22-heptaene-7,14,24-trione

C30H28O12 (580.1581)

(2r,3s,4s,5r,6r)-2-{[(2r,3r)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-2,3-dihydro-1-benzopyran-3-yl]oxy}-3,5-dihydroxy-6-methyloxan-4-yl (2e)-3-phenylprop-2-enoate

C30H28O12 (580.1581)

{6-[4-(5,7-dihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl)phenoxy]-3,4,5-trihydroxyoxan-2-yl}methyl 3-(4-hydroxyphenyl)prop-2-enoate

C30H28O12 (580.1581)

(2s,3r,4s,5r,6r)-3,5-dihydroxy-2-{[(2s)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-6-(hydroxymethyl)oxan-4-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C30H28O12 (580.1581)

ethyl (2s,3s)-2-(3,4-dihydroxyphenyl)-4-[(1e)-3-{[(2r)-3-(3,4-dihydroxyphenyl)-1-methoxy-1-oxopropan-2-yl]oxy}-3-oxoprop-1-en-1-yl]-7-hydroxy-2,3-dihydro-1-benzofuran-3-carboxylate

C30H28O12 (580.1581)

(1r,3s,4r,5r,7r,8r,16s,24r,26r,27s)-11,13,16,18,20,27-hexahydroxy-5,7,24,26-tetramethyl-2,6,25,30-tetraoxaoctacyclo[15.11.1.1¹,⁴.0³,⁸.0³,¹⁶.0¹⁰,¹⁵.0²¹,²⁹.0²³,²⁸]triaconta-10,12,14,17(29),18,20,23(28)-heptaene-9,22-dione

(1r,3s,4r,5r,7r,8r,16s,24r,26r,27s)-11,13,16,18,20,27-hexahydroxy-5,7,24,26-tetramethyl-2,6,25,30-tetraoxaoctacyclo[15.11.1.1¹,⁴.0³,⁸.0³,¹⁶.0¹⁰,¹⁵.0²¹,²⁹.0²³,²⁸]triaconta-10,12,14,17(29),18,20,23(28)-heptaene-9,22-dione

C30H28O12 (580.1581)

(2r,3s)-2-(3,4-dihydroxyphenyl)-6-[(1s,2r)-1-(3,4-dihydroxyphenyl)-2-hydroxy-3-(2,3,4-trihydroxyphenyl)propyl]-3,4-dihydro-2h-1-benzopyran-3,7,8-triol

C30H28O12 (580.1581)

11,13,16,18,20,27-hexahydroxy-5,7,24,26-tetramethyl-2,6,25,30-tetraoxaoctacyclo[15.11.1.1¹,⁴.0³,⁸.0³,¹⁶.0¹⁰,¹⁵.0²¹,²⁹.0²³,²⁸]triaconta-10,12,14,17(29),18,20,23(28)-heptaene-9,22-dione

11,13,16,18,20,27-hexahydroxy-5,7,24,26-tetramethyl-2,6,25,30-tetraoxaoctacyclo[15.11.1.1¹,⁴.0³,⁸.0³,¹⁶.0¹⁰,¹⁵.0²¹,²⁹.0²³,²⁸]triaconta-10,12,14,17(29),18,20,23(28)-heptaene-9,22-dione

C30H28O12 (580.1581)